|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.043 USD | +13.16% |
|
-2.27% | +95.45% |
| 04-15 | Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
| 03-12 | Cell MedX Corp. announced that it has received $0.075 million in funding | CI |
Cell MedX Corp. announced that, effective April 30, 2018, Dr. Terrance Owen resigned from his management and directorship positions with Cell MedX. The resignation of Dr. Owen was not due to any disagreements relating to the company's operations, policies or practices.
The company has not filled the vacancies created by Dr. Owen's resignation as CEO and as a member of the Board of Directors. The company is currently reviewing possible candidates.
| 1st Jan change | Capi. | |
|---|---|---|
| +95.45% | 12.78M | |
| +40.80% | 53.67B | |
| +35.79% | 38.86B | |
| -8.05% | 38.76B | |
| -8.98% | 27.27B | |
| +10.69% | 25.91B | |
| -16.21% | 20.29B | |
| +31.00% | 12.78B | |
| +28.51% | 12.18B | |
| -1.67% | 11.96B |
CELL MEDX CORP. 